Research analysts at StockNews.com assumed coverage on shares of Lifeway Foods (NASDAQ:LWAY – Get Rating) in a research note issued to investors on Sunday. The brokerage set a "strong-buy" rating on the stock.
Other research analysts have also issued reports about the company. TheStreet lowered Lifeway Foods from a "b-" rating to a "c" rating in a research report on Thursday, September 22nd. Noble Financial raised Lifeway Foods from a "market perform" rating to an "outperform" rating and set a $10.00 price target on the stock in a research report on Wednesday, November 16th.
Get Lifeway Foods alerts:Lifeway Foods Price Performance
Shares of Lifeway Foods stock opened at $5.55 on Friday. The stock's fifty day moving average is $6.40 and its 200-day moving average is $5.89. The company has a quick ratio of 1.55, a current ratio of 2.18 and a debt-to-equity ratio of 0.11. Lifeway Foods has a 12-month low of $4.55 and a 12-month high of $9.00.
Lifeway Foods (NASDAQ:LWAY – Get Rating) last announced its earnings results on Monday, November 14th. The company reported $0.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.04. The company had revenue of $38.14 million for the quarter, compared to analyst estimates of $35.00 million. Lifeway Foods had a return on equity of 0.23% and a net margin of 0.08%.Insiders Place Their Bets
In other Lifeway Foods news, Director Ludmila Smolyansky sold 5,000 shares of the company's stock in a transaction dated Wednesday, December 14th. The stock was sold at an average price of $6.67, for a total value of $33,350.00. Following the transaction, the director now directly owns 2,383,120 shares of the company's stock, valued at approximately $15,895,410.40. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, major shareholder Edward Smolyansky sold 10,000 shares of the stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $7.58, for a total transaction of $75,800.00. Following the completion of the sale, the insider now owns 2,000,112 shares in the company, valued at approximately $15,160,848.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Ludmila Smolyansky sold 5,000 shares of the stock in a transaction that occurred on Wednesday, December 14th. The shares were sold at an average price of $6.67, for a total value of $33,350.00. Following the sale, the director now owns 2,383,120 shares of the company's stock, valued at approximately $15,895,410.40. The disclosure for this sale can be found here. Insiders have sold a total of 41,883 shares of company stock valued at $293,966 in the last three months. Insiders own 50.34% of the company's stock.
Institutional Trading of Lifeway Foods
An institutional investor recently bought a new position in Lifeway Foods stock. Voss Capital LLC purchased a new stake in Lifeway Foods, Inc. (NASDAQ:LWAY – Get Rating) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 58,079 shares of the company's stock, valued at approximately $332,000. Voss Capital LLC owned approximately 0.37% of Lifeway Foods as of its most recent SEC filing. Institutional investors own 29.36% of the company's stock.
About Lifeway Foods
(Get Rating)
Lifeway Foods, Inc produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types, including low fat, non-fat, whole milk, protein, and BioKefir. The company also offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; cupped kefir and Icelandic Skyr, a line of strained kefir and yogurt products; and frozen kefir in soft serve and pint-size containers.
Further Reading
- Get a free copy of the StockNews.com research report on Lifeway Foods (LWAY)
- MarketBeat: Week in Review 01/02-01/06
- Why is the CrowdStrike Stock Price Struggling?
- Four Undervalued Healthcare Stocks for 2023
- WWE Stock: Vince McMahon Wants Back In The Show
- NVIDIA Is Bottoming But Don't Buy It Just Yet
Receive News & Ratings for Lifeway Foods Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeway Foods and related companies with MarketBeat.com's FREE daily email newsletter.